AzTrials
AzTrials

Infant PrematureNCT04624347

NEOVIDEO : Impact of Monitoring Motor Activity by Video Analysis on the Sleep of Very Preterm Infants

A study testing Access to video and movement curves in people with Infant Premature and Growth and Development, run by Rennes University Hospital at 2 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Very premature birth and the necessary hospitalization expose to a risk of morbidity and mortality which impacts the neurodevelopmental prognosis. Sleep and behavior monitoring have not been developed in the neonatal units. Read more about this study

Who is it for?
Ages 23 to 32 weeks
What is being tested?
Access to video and movement curves
Could I receive a placebo?
No, everyone receives an active treatment
How many people
74 participants
Where
2 sitesFrance
Study dates
17 Nov 2020to 22 Sep 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 23 to 32 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • New born :
  • hospitalized in neonatology,
  • at least one of whose legal representatives has given free, informed and written consent,
  • term of birth <32 WA, postnatal age> 15 days and post-conceptual age between [30-38] WA,
  • affiliated to a social security scheme
  • Caregivers:
Show all 9Show fewer
  • having at least 1 year of practical experience in neonatology,
  • having been trained in the clinical basics of evaluating newborn sleep,
  • having given their consent to participate.

Who cannot join

  • New born :
  • sedative or curare treatment (opiates, benzodiazepines, curare, barbiturates) in the last 24 hours,
  • chromosomal abnormalities identified
  • Planned discharge date incompatible with the completion of the entire study
  • No criteria for caregivers

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • Pôle Femme Mère Enfant

    Brest, 29200

  • CHU Rennes Hôpital Sud

    Rennes, Brittany Region, 35000

Other trials in France

About this study

Very premature birth and the necessary hospitalization expose to a risk of morbidity and mortality which impacts the neurodevelopmental prognosis. Sleep and behavior monitoring have not been developed in the neonatal units. This has to be improved since it is known from clinical and animal studies that the quality, organization and quantity of sleep in very preterm infants impact neurological development and brain plasticity.

The collection system provide neonatal care nurse with access to motion curves (evaluated by signal processing of live video) and real-time infrared video (also available in low-light conditions).

This new non-invasive technology allows an evaluation of the activity cycles of the newborn by the caregivers which until now was only accessible occasionally by short recordings of actigraphy or polysomnography. The investigators wish to demonstrate that this can contribute to an organization of care that respects the sleep patterns of the newborn, which they know to condition the neurodevelopmental prognosis.

Read the detailed description

According to the EuroPeristat 2014 report, 1% of births are very preterm infants. Very premature birth and the necessary hospitalization expose to a risk of morbidity and mortality which impacts the neurodevelopmental prognosis. Sleep and behavior monitoring have not been developed in the neonatal units. This has to be improved since it is known from clinical and animal studies that the quality, organization and quantity of sleep in very preterm infants impact neurological development and brain plasticity. The publications suggest that alterations in sleep could have a significant impact on acquisitions in the areas of learning, memory, sensory development and behavior, as well as in the area of cardiorespiratory regulation. It has been shown that the implementation of developmental care practices (taking into account lighting, noise, the position of newborns and their rhythms) could have short-term beneficial effects on the sleep of very preterm infants. However, studies remain very limited in number. The investigators propose to build on the infrastructure developed as part of the H2020 DigiNewB project (http://www.digi-newb.eu/), which can provide neonatal care providers with access to motion curves (evaluated by signal processing of live video) and real-time infrared video (also available in low-light conditions).The collection system is functional, allows continuous analysis of videos to quantify movement and is suitable for incubators and neonatal beds. This new non-invasive technology allows an evaluation of the activity cycles of the newborn by the caregivers which until now was only accessible occasionally by short recordings of actigraphy or polysomnography. The investigators wish to demonstrate that this can contribute to an organization of care that respects the sleep patterns of the newborn, which they know to condition the neurodevelopmental prognosis.

Being tested
Access to video and movement curves
Medical subject headings
Premature Birth, Nervous System Diseases, Sleep Deprivation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Access to video and movement curvesBehavioural

    intervention of caregivers with access to videos and motion curves of the premature infant

Study groups in NCT04624347
Study groupRoleWhat they receive
Acess to Videos and Movement curvesExperimentalwith caregivers' access to videos and movement curves (4 days)
Receives: Behavioral: Access to video and movement curves
No Acess to Video and Movement curvesNo interventionwithout caregivers' access to videos and movement (4 days)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quantification of the percentage of time spent in sleep

    Quantification of the percentage of time spent in sleep (stage 1 + 2 of the neurobehavioral classification of Prechtl in 5 stages compared to the total duration of the analyzable tracing) by a supervised expert, viewing the blinded sequences of the condition tested (with and without access caregivers to video and movement curves).

    Measured: for 8 days

Secondary outcomes (11)
  1. Quantification of the ratio of time spent in calm sleep / time spent in restless sleep .

    Prechtl stage 1 / stage 2 ratio

    Measured: for 8 days

  2. - Quantification of the percentage of time spent in the 5 stages of Prechtl / total analyzable tracing time.

    Measured: for 8 days

  3. - Quantification of sleep fragmentation and the different types of transitions: number and duration of awakening periods

    Measured: for 8 days

  4. - Quantification of sleep fragmentation and the different types of transitions: number and duration of movement periods (periods defined by successions of movements spaced less than 5 seconds apart)

    movement periods = periods defined by successions of movements spaced less than 5 seconds apart

    Measured: for 8 days

  5. - Quantification of sleep fragmentation and the different types of transitions: classification of all transitions between stages

    Measured: for 8 days

  6. - Care interventions: Quantification of the number and estimated stage of sleep at their initiation (in the 2 minutes preceding the intervention)

    Measured: for 8 days

  7. - Care interventions: Quantification of the duration and estimated stage of sleep at their initiation (in the 2 minutes preceding the intervention)

    Measured: for 8 days

  8. - Care interventions: Quantification of the type (noise or manual intervention) and estimated stage of sleep at their initiation (in the 2 minutes preceding the intervention)

    Measured: for 8 days

  9. - Textual analysis (lexical field) of the interview with the parents on their feelings about the device

    Measured: At the end of 8 days recordings

  10. - Textual analysis (lexical field) of the interview with the nursery nurses on their feelings about the device

    Measured: At the end of 8 days recordings

  11. - Analysis of the score of the "Ages and Stages questionnaires / Second Edition" sent to parents before their child's 24-month visit.

    Evaluate the child's skills in the various areas of his development. Questionnaire with 5 sections (Communication, Gross motor skills,Fine motor skills,Problem solving, Individual or social skills).

    Results sheet allowing rapid interpretation (positivity threshold for each sphere) and recommendations for each developmental area screened.

    Measured: at 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Nov 2020
  2. Study start17 Nov 2020
  3. Primary completion17 May 2022
  4. Study completion22 Sep 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Model description
Controlled, bicentric, single-blind, cross-over study with randomization of the sequence order (with and without caregivers' access to videos and movement curves).
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
74 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04624347
Sponsor's protocol ID
35RC18_8855_NEOVIDEO
Status last verified
Apr 2024
First submitted
5 Nov 2020
Last updated
16 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Access to video and movement curves in people with Infant Premature and Growth and Development, run by Rennes University Hospital at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quantification of the percentage of time spent in sleep (time frame: for 8 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in